179 results
Page 5 of 9
8-K
EX-10.2
ce274m
20 Feb 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
kx1lx4ott 385mbl
20 Feb 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
vdp vssw9o
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.3
q5i4llfvjkmu1g8pne4
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.4
0fyq6oiz
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.6
2mut1
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.7
ie8ui0
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.1
n2vu1e
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
8-K
EX-10.2
ajb1zx bk
9 Feb 12
Cytomedix Expands Commitment to Regenerative Medicine with Acquisition of Aldagen
12:00am
S-1
EX-10.26
v08 cpjh8qt4i88
19 Nov 10
IPO registration
12:00am
8-K
EX-10.2
w06s7ewr
8 Oct 10
Cytomedix Secures $13 Million in Committed Funding
12:00am
8-K
EX-10.1
r6y h273azoz0t1q
8 Oct 10
Cytomedix Secures $13 Million in Committed Funding
12:00am
8-K
EX-10.3
jhnk4pt il6kkny
8 Oct 10
Cytomedix Secures $13 Million in Committed Funding
12:00am
8-K
EX-10.4
hpj6qz tutt8
8 Oct 10
Cytomedix Secures $13 Million in Committed Funding
12:00am